Stockreport

Coherus divests Udenyca franchise to Intas for up to $558.4m [Yahoo! Finance]

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
PDF Coherus obtained $483.4m in cash upfront on its completion, and $118.4m for the therapy's inventory. The amount is subject to post-closing adjustments. Coherus now [Read more]